Cryo-EM is helping redefine the future of structural biology, vaccine development, and pharmaceutical innovation by enabling the atomic-level 3D visualization of proteins, viruses, and molecular complexes. These capabilities allow for the detailed study of fine cellular structures and intricate biological structures at sub-cellular and molecular scales.
While it’s the scientific breakthroughs that often capture headlines, the infrastructure challenges behind them are rarely discussed.
The reality is that Cryo-EM workflows are among the most data-intensive pipelines in modern life sciences.
Each project can generate anywhere from 10 TB to 200+ TB of high-resolution microscopy data, often composed of tens of thousands of small image files and video sequences. This data is typically born in the wet lab where microscopes capture biological samples, but the heavy computational lifting – including motion correction, CTF estimation, particle picking, 2D classification, and 3D refinement – requires GPU-dense compute capacity, most of which is found only in massive datacenters or one of the public cloud platforms.
For many organizations, this creates an expensive and operationally complex problem.
Data must be copied from lab environments to HPC or cloud infrastructure, which means so much more of everything needs to be in place for every project. Additional storage must be provisioned to house replicated datasets – up to 200TB of capacity per project per site. Replication pipelines must be implemented and maintained for every project and every endpoint, and valuable staff time is consumed validating building data pipelines, monitoring active replication tasks, and verifying data integrity after every major transfer.
Not only does all this data duplication and environment complexity add to the cost of every project, but it can stretch project timelines out too. Scientists are often left waiting hours, or even days, before processing can begin, while final results frequently need to be transferred back yet again for validation, visualization, and broader collaboration.
There are even more hidden costs that extend far beyond storage capacity alone. Replication expands infrastructure footprints, increases networking demands, adds operational scripting complexity, requires deeper IT oversight, and creates significant human dependency across multiple teams. Microscope specialists, IT administrators, cloud architects, bioinformatics teams, storage engineers, and researchers all become links in a fragile operational chain, all working overtime to ensure that data arrives where it needs to be, consistent and on time.
Imagine a simpler approach: a filesystem that touched every point in the organization simultaneously; where data created in one location was instantly accessible from anywhere else.
Consider a pharmaceutical organization running three concurrent drug discovery programs across sites in Palo Alto, Boston, and a CRO partner in the UK. Under a traditional replication model, each site maintains its own copy of every dataset — storage capacity multiplied by three, replication pipelines maintained across every endpoint, and a 12-to-24-hour staging window before any cloud GPU cluster can begin processing. With a unified data fabric, that same organization operates from a single copy of each dataset: instrument data written in Palo Alto is immediately visible to GPU clusters in AWS, analysis pipelines running in Boston, and the CRO team in the UK — concurrently, without a single replication job running. IT complexity collapses, storage overhead drops proportionally, and the time between data acquisition and actionable results shrinks from days to hours.
Qumulo’s hybrid data architecture fundamentally changes this equation.
Qumulo’s file system exposes data across all endpoints via industry-standard protocols — NFS v3/v4.1, SMB 3.0, and S3-compatible object API — meaning existing bioinformatics pipelines, HPC job schedulers, and cloud-native tools mount or access the namespace without modification. The global namespace maintains a single, coherent metadata plane across on-premises nodes and cloud instances simultaneously: directory listings, file attributes, and inode state are consistent regardless of which endpoint issues the request, eliminating the split-brain conditions and stale-cache failures common in traditional replication architectures. Cloud Accelerators present as standard NFS mount points to cloud compute instances, allowing GPU workloads to begin processing as soon as the first files are visible in the namespace — with intelligent read-ahead and prefetch handling the latency gap between the physical data location and the cloud endpoint — while Edge Accelerator appliances at instrument sites absorb high-bandwidth write streams from detectors and scanners directly into the fabric without intermediate staging.
By eliminating unnecessary replication and enabling unified global access to datasets, Qumulo empowers organizations to transform Cryo-EM from a fragmented logistical challenge into a streamlined scientific workflow. Rather than forcing data through repeated cycles of copying, validating, transferring, and restaging, the Cloud Data Platform enables immediate global availability, allowing processing to occur wherever compute resources are most effective while ensuring results are instantly accessible everywhere they are needed.
By connecting wet labs, cloud HPC environments, and research teams in real time through a unified global namespace, Qumulo enables a single copy of the data to exist in one physical location while still being instantly accessible across sites, platforms, and clouds. There is no need for duplicate datasets, no dependency on brittle transfer scripts, no repeated validation cycles, and no operational drag caused by traditional replication methods.
All of this takes place without replicating a single dataset, meaning there’s only one copy of the data to store and manage, so the organization’s IT teams dramatically reduce storage overhead, management complexity, and time-to-value.
Built by pairing Qumulo’s scalable, high-performance file system – available in the Marketplace of major hyperscalers such as AWS, Azure and GCP, or deployed on-premises using hardware from your preferred OEM – with the stretched file-system capabilities of Qumulo Cloud Data Fabric, the Qumulo Cloud Data Platform creates a true hybrid environment for life sciences, one that connects data generation, GPU acceleration, and global collaboration in real time. Optional Edge Accelerator appliances connect remote sites and wet labs back to the fabric, while Cloud Accelerators open ephemeral portals that project data from where it lives to the cloud, enabling workloads to burst to available cloud GPU capacity and scale compute on demand when local resources are constrained – all without having to move any data.
For pharmaceutical and biotech organizations, this means accelerating molecular modeling initiatives, shortening therapeutic discovery timelines from weeks to days, enabling more agile vaccine development, maximizing expensive GPU resource utilization, and ultimately reducing the cost and complexity of R&D itself.
As AI, HPC, and advanced biological imaging continue to converge, the organizations that gain strategic advantage will not simply be those with the best microscopes or the largest GPU clusters, they will be those that build infrastructure capable of removing data gravity altogether..
The next frontier in life sciences is not just compute.
It is intelligent data architecture, and solutions like Qumulo Cloud Data Fabric are helping make that future possible.